ESMCX
Price
$12.41
Change
+$0.02 (+0.16%)
Updated
Jul 31 closing price
Net Assets
164.42M
FHJUX
Price
$50.27
Change
-$0.12 (-0.24%)
Updated
Jul 31 closing price
Net Assets
977.47M
Interact to see
Advertisement

ESMCX vs FHJUX

ESMCX vs FHJUX Comparison Chart in %
View a ticker or compare two or three
VS
ESMCX vs. FHJUX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESMCX is a StrongBuy and FHJUX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FHJUX has more cash in the bank: 977M vs. ESMCX (164M). ESMCX pays higher dividends than FHJUX: ESMCX (2.81) vs FHJUX (1.76). ESMCX was incepted earlier than FHJUX: ESMCX (26 years) vs FHJUX (12 years). ESMCX (2.19) is less costly to investors than FHJUX (1.07). ESMCX is a more actively managed with annual turnover of: 147.00 vs. FHJUX (51.00). FHJUX has a lower initial minimum investment than ESMCX: FHJUX (0) vs ESMCX (1000). FHJUX annual gain was more profitable for investors over the last year : 17.72 vs. ESMCX (-17.62). FHJUX return over 5 years is better than : 15.00 vs. ESMCX (-14.00).
ESMCXFHJUXESMCX / FHJUX
Total Expense Ratio2.001.07187%
Annual Report Gross Expense Ratio2.191.07205%
Fund Existence26 years12 years-
Gain YTD11.6017.645152%
Front LoadN/A6%-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets164M977M17%
Annual Yield % from dividends2.811.76160%
Returns for 1 year-17.6217.72-99%
Returns for 3 years0.9357.792%
Returns for 5 years-14.0015.00-93%
Returns for 10 years26.0757.3545%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLVIX90.271.58
+1.78%
Invesco Global Focus R6
BMGAX26.250.11
+0.42%
BlackRock Mid-Cap Growth Equity Inv A
RLBCX40.120.08
+0.20%
American Funds American Balanced R-3
VSFAX29.61-0.10
-0.34%
Federated Hermes MDT Small Cap Value A
PHLQX50.92-0.59
-1.15%
PGIM Jennison Health Sciences R6